Luca Bertamini

636 total citations
15 papers, 175 citations indexed

About

Luca Bertamini is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Luca Bertamini has authored 15 papers receiving a total of 175 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Luca Bertamini's work include Multiple Myeloma Research and Treatments (10 papers), Acute Myeloid Leukemia Research (7 papers) and Protein Degradation and Inhibitors (7 papers). Luca Bertamini is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Acute Myeloid Leukemia Research (7 papers) and Protein Degradation and Inhibitors (7 papers). Luca Bertamini collaborates with scholars based in Italy and United States. Luca Bertamini's co-authors include Francesca Gay, Mattia D’Agostino, Mario Boccadoro, Stefania Oliva, Stefania Oliva, Michèle Cavo, Massimo Offidani, Elena Zamagni, Renato Zambello and Andréa Capra and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Luca Bertamini

15 papers receiving 175 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luca Bertamini Italy	8	148	124	94	15	13	15	175
Vadim Doronin Russia	7	155 1.0×	134 1.1×	82 0.9×	40 2.7×	18 1.4×	19	218
Ravi Vij United States	4	137 0.9×	117 0.9×	60 0.6×	11 0.7×	9 0.7×	13	171
Georgi Mihaylov Bulgaria	8	157 1.1×	119 1.0×	77 0.8×	20 1.3×	8 0.6×	22	205
Elisha J. Dettman United States	7	64 0.4×	124 1.0×	61 0.6×	19 1.3×	12 0.9×	14	163
Yvonne Dinh United States	8	205 1.4×	157 1.3×	100 1.1×	22 1.5×	14 1.1×	20	246
Pia Sondergeld Germany	4	220 1.5×	139 1.1×	135 1.4×	40 2.7×	8 0.6×	4	252
Luísa Viterbo Portugal	8	203 1.4×	163 1.3×	109 1.2×	31 2.1×	21 1.6×	19	235
Laura Rosiñol Spain	5	152 1.0×	94 0.8×	89 0.9×	29 1.9×	8 0.6×	18	159
María Ángeles Montalbán Spain	4	125 0.8×	81 0.7×	51 0.5×	44 2.9×	10 0.8×	7	146
José-María Arguiñano Spain	2	125 0.8×	104 0.8×	55 0.6×	15 1.0×	9 0.7×	4	128

Countries citing papers authored by Luca Bertamini

Since Specialization

Citations

This map shows the geographic impact of Luca Bertamini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Bertamini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Bertamini more than expected).

Fields of papers citing papers by Luca Bertamini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Bertamini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Bertamini. The network helps show where Luca Bertamini may publish in the future.

Co-authorship network of co-authors of Luca Bertamini

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Bertamini. A scholar is included among the top collaborators of Luca Bertamini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Bertamini. Luca Bertamini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Martinelli, Nicola, Luca Bertamini, Sara De Fanti, et al.. (2024). Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study. GeroScience. 47(2). 2149–2157. 1 indexed citations

Bertamini, Luca, et al.. (2022). Beyond Clinical Trials in Patients With Multiple Myeloma: A Critical Review of Real-World Results. Frontiers in Oncology. 12. 844779–844779. 13 indexed citations

Bertamini, Luca, Mattia D’Agostino, & Francesca Gay. (2021). MRD Assessment in Multiple Myeloma: Progress and Challenges. Current Hematologic Malignancy Reports. 16(2). 162–171. 35 indexed citations

Gay, Francesca, Roberto Mina, Delia Rota‐Scalabrini, et al.. (2021). Carfilzomib-based induction/consolidation with or without autologous transplant (ASCT) followed by lenalidomide (R) or carfilzomib-lenalidomide (KR) maintenance: Efficacy in high-risk patients.. Journal of Clinical Oncology. 39(15_suppl). 8002–8002. 19 indexed citations

Nathwani, Nitya, Luca Bertamini, Rahul Banerjee, et al.. (2021). When and How to Treat Relapsed Multiple Myeloma. American Society of Clinical Oncology Educational Book. 41(41). 358–375. 8 indexed citations

Gay, Francesca, Pellegrino Musto, Delia Rota Scalabrini, et al.. (2020). Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in the Randomized Forte Trial. Blood. 136(Supplement 1). 35–37. 32 indexed citations

Bertamini, Luca, Mariella Grasso, Mattia D’Agostino, et al.. (2020). Poor Prognosis of Multiple Myeloma Predicted By High Levels of Circulating Plasma Cells Is Independent from Other High-Risk Features but Is Modulated By the Achievement of Minimal Residual Disease Negativity. Blood. 136(Supplement 1). 12–13. 12 indexed citations

Bertamini, Luca, Francesca Bonello, Mario Boccadoro, & Sara Bringhen. (2020). New drugs in early development for treating multiple myeloma: all that glitters is not gold. Expert Opinion on Investigational Drugs. 29(9). 989–1004. 5 indexed citations

D’Agostino, Mattia, Luca Bertamini, Stefania Oliva, Mario Boccadoro, & Francesca Gay. (2019). Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies. Cancers. 11(12). 2015–2015. 25 indexed citations

10.

Bonello, Francesca, et al.. (2019). Moving Toward Continuous Therapy in Multiple Myeloma. SHILAP Revista de lepidopterología. 1(4). 189–189. 4 indexed citations

11.

Bertamini, Luca, Jacopo Nanni, Giovanni Marconi, et al.. (2018). Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia. BMC Cancer. 18(1). 16 indexed citations

12.

Marconi, Giovanni, Maria Chiara Abbenante, Stefania Paolini, et al.. (2018). Mitoxantrone, Etoposide and Cytarabine (MEC) Can Induce Deep Complete Remission and Is an Effective Bridge Therapy to Allotransplantation (SCT) in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients. Blood. 132(Supplement 1). 4036–4036. 1 indexed citations

13.

Bertamini, Luca, Claudia Sala, Nicola Martinelli, et al.. (2018). Abstract 1229: Clonal hematopoiesis of indeterminate potential (CHIP), centenarians and age-related cardiovascular risk: Is TET2 the culprit. Cancer Research. 78(13_Supplement). 1229–1229. 1 indexed citations

14.

Bertamini, Luca, Claudia Sala, Nicola Martinelli, et al.. (2017). Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Patients with Coronary Artery Disease and in Centenarians. Further Clues Linking Chip with Cardiovascular Risk. Blood. 130. 1144–1144. 1 indexed citations

15.

Marconi, Giovanni, Maria Chiara Fontana, Cristina Papayannidis, et al.. (2017). Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia.. Journal of Clinical Oncology. 35(15_suppl). 7038–7038. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact